ME
DNA icon

McIlrath & Eck’s Ginkgo Bioworks DNA Stock Holding History

McIlrath & Eck’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$458 – 962
2024
Q1 		$458 Buy
+10
New +$518 ﹤0.01% 896
2023
Q4 		– Sell
-10
Closed -$715 – 930
2023
Q3 		$715 Hold
10
– – ﹤0.01% 832
2023
Q2 		$735 Hold
10
– – ﹤0.01% 839
2023
Q1 		$525 Hold
10
– – ﹤0.01% 874
2022
Q4 		$668 Buy
10
+1
+11% +$92 ﹤0.01% 818
2022
Q3 		$1K Hold
9
– – ﹤0.01% 794
2022
Q2 		$1K Hold
9
– – ﹤0.01% 769
2022
Q1 		$1K Hold
9
– – ﹤0.01% 760
2021
Q4 		$3K Hold
9
– – ﹤0.01% 689
2021
Q3 		$4K Buy
+9
New +$4.38K ﹤0.01% 641

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return